Providence Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.47M | Buy |
10,099
+105
| +1% | +$24.5K | 1.57% | 18 |
|
|
2025
Q4 | $2.03M | Sell |
9,994
-250
| -2% | -$49.4K | 1.27% | 22 |
|
|
2025
Q3 | $1.91M | Sell |
10,244
-669
| -6% | -$115K | 1.21% | 24 |
|
|
2025
Q2 | $1.86M | Buy |
10,913
+269
| +3% | +$41.3K | 1.28% | 22 |
|
|
2025
Q1 | $1.64M | Buy |
10,644
+1,029
| +11% | +$161K | 1.24% | 27 |
|
|
2024
Q4 | $1.38M | Buy |
9,615
+30
| +0.3% | +$4.65K | 1.05% | 30 |
|
|
2024
Q3 | $1.57M | Buy |
9,585
+145
| +2% | +$23.1K | 1.16% | 29 |
|
|
2024
Q2 | $1.39M | Buy |
9,440
+293
| +3% | +$43.6K | 1.11% | 29 |
|
|
2024
Q1 | $1.43M | Sell |
9,147
-3,575
| -28% | -$569K | 1.22% | 26 |
|
|
2023
Q4 | $9.26M | Buy |
12,722
+4,039
| +47% | +$619K | 8.36% | 1 |
|
|
2023
Q3 | $1.34M | Buy |
8,683
+100
| +1% | +$16.5K | 1.5% | 22 |
|
|
2023
Q2 | $1.4M | Sell |
8,583
-600
| -7% | -$96.8K | 1.55% | 22 |
|
|
2023
Q1 | $1.49M | Buy |
9,183
+110
| +1% | +$17.8K | 1.1% | 32 |
|
|
2022
Q4 | $1.62M | Buy |
9,073
+100
| +1% | +$17.3K | 1.2% | 28 |
|
|
2022
Q3 | $1.56M | Sell |
8,973
-115
| -1% | -$19.5K | 1.17% | 28 |
|
|
2022
Q2 | $1.62M | Buy |
9,088
+808
| +10% | +$144K | 1.17% | 31 |
|
|
2022
Q1 | $1.48M | Buy |
8,280
+15
| +0.2% | +$2.55K | 0.95% | 34 |
|
|
2021
Q4 | $1.43M | Buy |
8,265
+353
| +4% | +$57.8K | 0.9% | 37 |
|
|
2021
Q3 | $1.27M | Buy |
7,912
+50
| +0.6% | +$8.53K | 0.88% | 37 |
|
|
2021
Q2 | $1.32M | Buy |
7,862
+75
| +1% | +$12.4K | 0.9% | 39 |
|
|
2021
Q1 | $1.28M | Buy |
7,787
+598
| +8% | +$96.8K | 0.94% | 38 |
|
|
2020
Q4 | $1.12M | Buy |
7,189
+194
| +3% | +$28.6K | 0.93% | 37 |
|
|
2020
Q3 | $1.04M | Sell |
6,995
-475
| -6% | -$70.3K | 1.03% | 36 |
|
|
2020
Q2 | $1.05M | Buy |
7,470
+146
| +2% | +$21.3K | 1.07% | 32 |
|
|
2020
Q1 | $938K | Buy |
7,324
+150
| +2% | +$21.3K | 1.13% | 33 |
|
|
2019
Q4 | $1.04M | Sell |
7,174
-450
| -6% | -$61K | 0.96% | 39 |
|
|
2019
Q3 | $986K | Buy |
7,624
+60
| +0.8% | +$7.91K | 0.88% | 37 |
|
|
2019
Q2 | $1.05M | Buy |
7,564
+92
| +1% | +$12.7K | 0.98% | 37 |
|
|
2019
Q1 | $1.05M | Buy |
7,472
+269
| +4% | +$36K | 0.99% | 37 |
|
|
2018
Q4 | $917K | Sell |
7,203
-202
| -3% | -$28.2K | 1.02% | 36 |
|
|
2018
Q3 | $1.02M | Sell |
7,405
-172
| -2% | -$22.9K | 0.93% | 37 |
|
|
2018
Q2 | $919K | Buy |
7,577
+75
| +1% | +$9.36K | 0.89% | 41 |
|
|
2018
Q1 | $934K | Buy |
+7,502
| New | +$1.01M | 1.38% | 27 |
|
Other funds holding JNJ
VCM
VPM
Providence Wealth Advisors's JNJ Position: Q1 2026 in Review
Providence Wealth Advisors increased its Johnson & Johnson (JNJ) stake by 1.1% in Q1 2026, buying an estimated $24.5K and bringing the position to 10,099 shares worth $2.47M. The position accounts for 1.57% of the portfolio, ranked #18.
Providence Wealth Advisors first reported a position in JNJ in Q1 2018 and has held it in 33 quarters since. The position peaked at $9.26M in Q4 2023. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Providence Wealth Advisors held 10,099 shares of Johnson & Johnson worth $2.47M as of Q1 2026.
- Providence Wealth Advisors bought 105 Johnson & Johnson shares in Q1 2026, an estimated $24.5K.
- Johnson & Johnson made up 1.57% of Providence Wealth Advisors's portfolio in Q1 2026, its #18 holding.
- Providence Wealth Advisors first reported a position in Johnson & Johnson in Q1 2018 and has held it in 33 quarters since.
- Providence Wealth Advisors's Johnson & Johnson position peaked at $9.26M in Q4 2023.
- 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Providence Wealth Advisors's 13F filing for Q1 2026, filed 5 May 2026.